Ibrutinib: A strong candidate for the future of mantle cell lymphoma treatment

Liang Zhang, Kate J. Newberry, Michael Wang

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)495-497
Number of pages3
JournalExpert Review of Clinical Immunology
Volume9
Issue number6
DOIs
StatePublished - Jun 2013

Keywords

  • Bruton's tyrosine kinase
  • ibrutinib
  • mantle cell lymphoma

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this